Volition announces first patient enrolled in ntu hospital's prospective validation study of nu.q® lung cancer test

Published study shows nu.q® lung cancer test differentiated malignant and benign nodules found by low dose ct screening. the study is expected to be completed by the end of 2025 henderson, nev.

VNRX Ratings Summary

VNRX Quant Ranking